Rainbow Childrens Medicare · NSE: RAINBOW · BSE: 543524
Q4 FY24 results · Jan–Mar 2024
Rainbow Childrens Medicare reported revenue from operations of ₹341.10 crore (up 7.6% from Q4 FY23) and net profit of ₹51.06 crore (down 5.2% from Q4 FY23) for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 341.10 | 316.97 | +7.6% | 335.96 | +1.5% |
| Other income | 12.78 | 8.90 | +43.6% | 8.61 | +48.4% |
| Total income | 353.88 | 325.86 | +8.6% | 344.57 | +2.7% |
| Profit before tax | 69.17 | 70.10 | −1.3% | 84.77 | −18.4% |
| Net profit for the period | 51.06 | 53.86 | −5.2% | 62.57 | −18.4% |
| Attributable to shareholders of the company | 50.97 | 53.59 | −4.9% | 62.12 | −18.0% |
| EPS, basic (₹) | 5.02 | 5.31 | −5.5% | 6.12 | −18.0% |
| Net margin (%) | 15.0 | 17.0 | 18.6 |
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 325.76 | 302.73 | +7.6% | 321.79 | +1.2% |
| Other income | 12.23 | 8.64 | +41.6% | 8.24 | +48.5% |
| Total income | 337.99 | 311.37 | +8.5% | 330.03 | +2.4% |
| Profit before tax | 68.42 | 71.55 | −4.4% | 82.55 | −17.1% |
| Net profit for the period | 50.44 | 55.58 | −9.3% | 61.14 | −17.5% |
| EPS, basic (₹) | 4.97 | 5.51 | −9.8% | 6.03 | −17.6% |
| Net margin (%) | 15.5 | 18.4 | 19.0 |
Consolidated
- Filed with BSE
- 21 May 2024, 12:35 IST
- Board meeting
- 19 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 21 May 2024, 12:35 IST
- Board meeting
- 19 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE